Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synthonix is a specialized chemistry company that provides high-quality medicinal chemistry building blocks and custom synthesis services to the pharmaceutical and biotechnology industries. Based in Raleigh, North Carolina, the company focuses on the design and production of unique small molecule scaffolds, fragments, and fluorinated compounds used in drug discovery. Synthonix maintains an extensive catalog of off-the-shelf compounds while also offering contract research services to support lead optimization and library synthesis. Their expertise in complex heterocyclic chemistry makes them a key partner for researchers seeking novel chemical space for therapeutic development. The company serves a global client base, ranging from academic institutions to major pharmaceutical corporations. By providing rare and innovative chemical intermediates, Synthonix helps accelerate the early stages of the drug development process.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synthonix.